Investigating the Role of CK2 in the DNA Damage Response

Total Page:16

File Type:pdf, Size:1020Kb

Investigating the Role of CK2 in the DNA Damage Response Investigating the Role of CK2 in the DNA Damage Response By Edward Strenk Miller A thesis presented to the College of Medical and Dental Sciences, The University of Birmingham, for the degree of DOCTOR OF PHILOSOPHY School of Cancer Sciences College of Medical and Dental Sciences University of Birmingham June 2014 University of Birmingham Research Archive e-theses repository This unpublished thesis/dissertation is copyright of the author and/or third parties. The intellectual property rights of the author or third parties in respect of this work are as defined by The Copyright Designs and Patents Act 1988 or as modified by any successor legislation. Any use made of information contained in this thesis/dissertation must be in accordance with that legislation and must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the permission of the copyright holder. Abstract Casein Kinase 2 (CK2) is a ubiquitous serine/threonine kinase. Due to its pleiotropic nature CK2 is involved in a multitude of cellular pathways including cell survival, proliferation and apoptosis. Therefore it has come as no surprise that a requirement for CK2 activity has been identified during the repair of DNA damage. Here we have described a novel role for CK2 in the response to DNA double-strand breaks. We have shown the mediator of DNA damage checkpoint 1 (MDC1) is constitutively phosphorylated by CK2, which is required for an interaction with the MRE11/RAD50/NBS1 (MRN) complex, via the FHA domain of NBS1. Moreover, disruption of this interaction resulted in loss of MRN foci following ionizing radiation and a partial G2/M checkpoint defect. Furthermore, the identification of three siblings presenting NBS/Seckel-like phenotypes with a unique mutation in the BRCT domain of NBS1, that phenocopied some of our observations, provided additional evidence for the importance of phospho-dependent interactions within the cell. Lastly, the identification of putative CK2 target residues in MRE11 and our preliminary data suggest that the kinase may play further roles in regulating the activity of the MRN complex that lie outside its activity in DNA double-strand break repair. This thesis is dedicated to my Mum and Dad for their unconditional support and encouragement and in loving memory of my Nan. You were right I did do it! Acknowledgements Firstly, I would like to thank my supervisors Dr Grant Stewart and Professor Malcolm Taylor for their continued support throughout my PhD, and for taking a chance on a Zoology graduate from Redditch. Extra gratitude must be given to Grant who has provided guidance, encouragement and confidence along the seemingly endless road of a part-time PhD. I would also like to thank Dr Roger Grand, who has always been there to offer advice both scientific and not, Dr Phil Byrd, my molecular biology mentor, Dr Manuel Stucki and members of his laboratory for their collaboration and Dr Xiaohua Wu and Dr Matthew Weitzman for generously providing reagents. Extended thanks go to members of the Stewart Laboratory, past and present Ellis, John, Helen and Rachael. In particular, both Dr Natasha Zlatanou and Dr Martin Higgs have provided valuable feedback in the writing of this thesis as well as sound scientific advice in the laboratory. Special thanks must go to Dr Kelly Endean whose support and friendship has been crucial throughout my PhD. I’m sorry you never did get to play your music in the laboratory. I would also like to thank Anoushka Thomas for both her friendship and constant optimism. I would also like to thank Dr Jim Last on so many levels. He has become a good friend, pillar of support, drinking companion and quiz buddy. I can take the tin hat off now right? Lastly my deepest gratitude goes to my family and friends, over the past 6 years or so they have kept me going in the harder times and without them I don’t think I would have made it to this point. I feel very lucky. Contents Chapter 1 General Introduction 1 1.1 Genomic instability and Cancer 1 1.2 The DNA damage response 3 1.2.1 ATM activation and the ATM-mediated DNA damage response 3 1.2.2 ATR activation and the ATR-mediated DNA damage reposnse 11 1.3 Cell cycle checkpoints in response to DNA damage 14 1.4 DNA double-strand break repair 16 1.4.1 Homologous recombination 17 1.4.1.1 Single-strand annealing and break-induced replication 22 1.4.2 Non-homologous end-joining 23 1.4.2.1 Alternative end-joining 26 1.4.3 Programmed double-strand breaks 27 1.5 Human DSB repair deficiency syndromes 31 1.5.1 Ataxia-Telangiectasia 31 1.5.2 Syndromes associated with mutations in the MRN complex 32 1.5.3 Syndromes associated with RNF168 mutations 38 1.5.4 Seckel syndrome 38 1.5.5 Ligase IV syndrome 41 1.5.6 RS-SCID (Associated with Artemis or XLF deficiency) 42 1.6 Mediators of DNA repair 43 1.6.1 Claspin 44 1.6.2 TopBP1 45 1.6.3 53BP1 46 1.6.4 BRCA1 48 1.6.5 MDC1 52 1.6.5.1 Structure 53 1.6.5.2 Function 56 1.6.5.2.1 DNA double-strand break repair 57 1.6.5.2.2 Cell cycle checkpoint control 61 1.6.5.2.3 Mitosis 62 1.6.5.3 Additional functions 63 1.6.6 The MRN complex 65 1.6.6.1 MRE11 66 1.6.6.2 RAD50 68 1.6.6.3 NBS1 69 1.6.6.4 Sensing DSBs and repair 71 1.6.6.5 MRN and cell cycle checkpoint control 74 1.6.6.6 Additional functions 76 Contents 1.7 Post-translational modifications and the DNA DSB damage response 78 1.7.1 Ubiquitylation in response to DNA DSBs 79 1.7.2 SUMOylation in response to DNA DSBs 83 1.7.3 Methylation and acetylation in response to DNA DSBs 85 1.7.4 Phosphorylation in response to DNA DSBs 88 1.8 Casein Kinase 2 (CK2) 90 1.8.1 Structure and activity 91 1.8.2 CK2 and cell cycle 93 1.8.3 CK2 and apoptosis 95 1.8.4 CK2 and the DNA damage response 95 1.9 Aims and objectives 99 Chapter 2 Materials and Methods 101 2.1 Molecular biology techniques 101 2.1.1 Bacterial strains 101 2.1.2 Media 102 2.1.3 Antibiotics 102 2.1.4 Primer design 102 2.1.5 Enzymes 102 2.1.6 Transformation of bacteria 103 2.1.7 DNA constructs 105 2.1.8 Small-scale preparation of DNA constructs 105 2.1.9 Large-scale preparation of DNA constructs 105 2.1.10 Measuring DNA concentrations 106 2.1.11 Cloning 106 2.1.11.1 PCR of a gene sequence from plasmid DNA constructs 106 2.1.11.2 Visualising PCR products via agrose gel electrophoresis 108 2.1.11.3 Gel extraction 108 2.1.11.4 Restriction digest and ligation 108 2.1.11.5 Screening of colonies via bacterial PCR 109 2.1.11.6 Sequencing 109 2.1.12 Mutagenesis 111 2.1.12.1 Primer design 111 2.1.12.2 PCR 113 2.1.12.3 Digestion and transformation 113 2.1.13 GST purification 113 2.1.14 Generation of cDNA for sequencing 115 2.1.14.1 RNA extraction and purification 115 2.1.14.2 Production of cDNA 115 2.2 Tissue culture techniques 116 2.2.1 Cell lines 116 2.2.2 Tissue culture media and solutions 116 Contents 2.2.3 Maintenance of cells 116 2.2.4 Cryopreservation of cell lines 118 2.2.5 Transient transfection of DNA constructs into cell lines 118 2.2.6 Generation of stable cell lines via retroviral transfection 119 2.2.7 Generation of stable Flp-In/T-Rex cell lines 120 2.2.8 Cell irradiation 121 2.2.9 Treatment of cells with DNA damaging agents 121 2.2.10 Transfection of cell lines with siRNA 121 2.2.11 Cell extraction and protein purification 122 2.2.12 G2/M checkpoint assay and cell cycle analysis 122 2.3 Protein biochemistry techniques 123 2.3.1 Protein dtermination 123 2.3.2 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 124 2.3.3 Visualisation of proteins 124 2.3.4 In-gel digestion of protein for analysis by mass spectrometry 124 2.3.5 In vitro kinase assay 125 2.3.6 GST pull-down 126 2.4 Immunochemistry techniques 126 2.4.1 Antibodies 126 2.4.2 Western blotting 126 2.4.3 Immunoprecipitation 127 2.4.4 Immunofluoresence 128 Chapter 3 Constitutive phosphorylation of MDC1 by CK2 is required for retention of the MRN complex at the sites of DNA double-strand breaks 132 3.1 Introduction 132 3.2 Results 134 3.2.1 Identification of potential phosphorylation motifs on MDC1 134 3.2.2 A N-terminal region of MDC1 is phosphorylated by CK2 in vitro and in vivo 137 3.2.3 Identification of MDC1 CK2 target sites by mass spectrometry analysis 142 3.2.4 MDC1 associates with CK2 in vivo in the presence and absence of damage 144 3.2.5 Loss of CK2 results in a persistent DNA damage response following IR 144 3.2.6 Loss of CK2 via siRNA or mutation of the CK2 target motifs does not affect MDC1 localisation 147 3.2.7 Loss of CK2 does not impair recruitment of other DNA damage factors following IR 149 3.2.8 siRNA-mediated reduction of CK2 results in loss of NBS1 foci following IR 151 Contents 3.2.9 The SDTD motif of MDC1 mediates its interaction with the MRN complex 153 3.2.10 The CK2 phosphorylated N-terminus of MDC1 interacts with NBS1 via its FHA domain 155 3.2.11 Abolishing the interaction between MDC1 and NBS1 results in a partial G2/M checkpoint defect 158 3.2.12 Identification of a Seckel-like family with a unique mutation in NBS1 162 3.2.13 ΔSer118 does not result in reduction of NBS1 protein levels or disrupt binding to MRE11 or RAD50 163 3.2.14 The ΔSer118 mutation disrupts NBS1 binding to MDC1 and ablates NBS1 foci following IR 171 3.2.15 ΔSer118 NBS1 mutation does not result in a G2/M checkpoint activation defect 173 3.3 Discussion 177 Chapter 4 Identification of putative CK2 motifs on MRE11 185 4.1 Introduction 185 4.2 Results 187 4.2.1 A C-terminal region of MRE11 is phosphorylated by CK2 in vitro 187 4.2.2 Generation of ATLD2 stable cell lines 193 4.2.3 Mutation of MRE11 putative CK2 sites does not lead to instability of the MRN
Recommended publications
  • The University of Chicago Genetic Services Laboratories Genetic
    The University of Chicago Genetic Services Laboratories 5841 S. Maryland Ave., Rm. G701, MC 0077, Chicago, Illinois 60637 Toll Free: (888) UC GENES (888) 824 3637 Local: (773) 834 0555 FAX: (312) 729 2808 [email protected] dnatesting.uchicago.edu CLIA #: 14D0917593 CAP #: 18827-49 Genetic Testing for Primary Microcephaly Autosomal recessive primary microcephaly (MCPH): • Congenital microcephaly (3 SD below the mean at birth or at least 4 SD below the mean at later ages) • Mental retardation (MR), but no other neurological findings (febrile or other mild seizures do not exclude the diagnosis) • Normal or mildly short stature that is less severe than the markedly small head circumference • Normal weight and appearance except for the microcephaly Brain imaging shows a mildly reduced number of gyri, and in some patients may also demonstrate agenesis of the corpus callosum or a few periventricular nodular heterotopia (numerous heterotopia suggest an alternative diagnosis). Prenatally, individuals have normal head size until approximately 20 weeks and decreased head size by 32 weeks, although this varies. The relative degree of microcephaly doesn’t vary throughout life and doesn’t vary within a family by more than 2 SD. MR is usually mild to moderate with no progressive decline or motor deficit [1]. Mutations in the ASPM [OMIM #605481] gene are the most common cause of MCPH [2]. Approximately 40% of patients (both consanguineous and non-consanguineous) with a strict diagnosis of MCPH have mutations in ASPM. However, very few patients (<10%) with a less restrictive phenotype have mutations in ASPM [3]. Thus, we expect a high detection rate for high-functioning MCPH, but a lower detection rate for low-functioning MCPH, especially if associated with other anomalies.
    [Show full text]
  • Congenital Microcephaly
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Sussex Research Online American Journal of Medical Genetics Part C (Seminars in Medical Genetics) ARTICLE Congenital Microcephaly DIANA ALCANTARA AND MARK O'DRISCOLL* The underlying etiologies of genetic congenital microcephaly are complex and multifactorial. Recently, with the exponential growth in the identification and characterization of novel genetic causes of congenital microcephaly, there has been a consolidation and emergence of certain themes concerning underlying pathomechanisms. These include abnormal mitotic microtubule spindle structure, numerical and structural abnormalities of the centrosome, altered cilia function, impaired DNA repair, DNA Damage Response signaling and DNA replication, along with attenuated cell cycle checkpoint proficiency. Many of these processes are highly interconnected. Interestingly, a defect in a gene whose encoded protein has a canonical function in one of these processes can often have multiple impacts at the cellular level involving several of these pathways. Here, we overview the key pathomechanistic themes underlying profound congenital microcephaly, and emphasize their interconnected nature. © 2014 Wiley Periodicals, Inc. KEY WORDS: cell division; mitosis; DNA replication; cilia How to cite this article: Alcantara D, O'Driscoll M. 2014. Congenital microcephaly. Am J Med Genet Part C Semin Med Genet 9999:1–16. INTRODUCTION mid‐gestation although glial cell division formation of the various cortical layers. and consequent brain volume enlarge- Furthermore, differentiating and devel- Congenital microcephaly, an occipital‐ ment does continue after birth [Spalding oping neurons must migrate to their frontal circumference of equal to or less et al., 2005]. Impaired neurogenesis is defined locations to construct the com- than 2–3 standard deviations below the therefore most obviously reflected clini- plex architecture and laminar layered age‐related population mean, denotes cally as congenital microcephaly.
    [Show full text]
  • Identification and Characterization of Genes Essential for Human Brain Development
    Identification and Characterization of Genes Essential for Human Brain Development The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Ganesh, Vijay S. 2012. Identification and Characterization of Genes Essential for Human Brain Development. Doctoral dissertation, Harvard University. Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:9773743 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Copyright © 2012 by Vijay S. Ganesh All rights reserved. Dissertation Advisor: Dr. Christopher A. Walsh Author: Vijay S. Ganesh Identification and Characterization of Genes Essential for Human Brain Development Abstract The human brain is a network of ninety billion neurons that allows for many of the behavioral adaptations considered unique to our species. One-fifth of these neurons are layered in an epithelial sheet known as the cerebral cortex, which is exquisitely folded into convolutions called gyri. Defects in neuronal number clinically present with microcephaly (Greek for “small head”), and in inherited cases these defects can be linked to mutations that identify genes essential for neural progenitor proliferation. Most microcephaly genes are characterized to play a role in the centrosome, however rarer presentations of microcephaly have identified different mechanisms. Charged multivesicular body protein/Chromatin modifying protein 1A (CHMP1A) is a member of the ESCRT-III endosomal sorting complex, but is also suggested to localize to the nuclear matrix and regulate chromatin.
    [Show full text]
  • Microcephaly Genes and Risk of Late-Onset Alzheimer Disease
    ORIGINAL ARTICLE Microcephaly Genes and Risk of Late-onset Alzheimer Disease Deniz Erten-Lyons, MD,*w Beth Wilmot, PhD,zy Pavana Anur, BS,z Shannon McWeeney, PhD,zyJ Shawn K. Westaway, PhD,w Lisa Silbert, MD,w Patricia Kramer, PhD,w and Jeffrey Kaye, MD*w Alzheimer’s Disease Neuroimaging Initiative ratio=3.41; confidence interval, 1.77-6.57). However, this associa- Abstract: Brain development in the early stages of life has been tion was not replicated using another case-control sample research suggested to be one of the factors that may influence an individual’s participants from the Alzheimer Disease Neuroimaging Initiative. risk of Alzheimer disease (AD) later in life. Four microcephaly We conclude that the common variations we measured in the 4 genes, which regulate brain development in utero and have been microcephaly genes do not affect the risk of AD or that their effect suggested to play a role in the evolution of the human brain, were size is small. selected as candidate genes that may modulate the risk of AD. We examined the association between single nucleotide polymorphisms Key Words: Alzheimer disease, microcephaly genes, cognitive tagging common sequence variations in these genes and risk of AD reserve in two case-control samples. We found that the G allele of (Alzheimer Dis Assoc Disord 2011;25:276–282) rs2442607 in microcephalin 1 was associated with an increased risk of AD (under an additive genetic model, P=0.01; odds Received for publication June 2, 2010; accepted December 2, 2010. enetics has been suggested to play a role in variations From the *Portland Veterans Affairs Medical Center; wDepartment of Gin cognitive function in late life.1 One way in which Neurology; zOregon Clinical and Translational Research Center; genes may play a role in cognitive function in late life is yDivision of Bioinformatics and Computational Biology, Depart- through providing an “initial endowment” that is more ment of Medical Informatics and Clinical Epidemiology; and JDivision of Biostatistics, Department of Public Health and resistant to age-related changes.
    [Show full text]
  • A Nonsense (C.3978G>A) Abnormal Spindle-Like, Microcephaly Associated (ASPM) Gene Mutation Is a Major Cause of Primary Microc
    African Journal of Biotechnology Vol. 10(34), pp. 6396-6400, 11 July, 2011 Available online at http://www.academicjournals.org/AJB DOI: 10.5897/AJB10.2571 ISSN 1684-5315 © 2011 Academic Journals Full Length Research Paper A nonsense (c.3978G>A) abnormal spindle-like, microcephaly associated (ASPM) gene mutation is a major cause of primary microcephaly in Pashtoon ethnic group of Pakistan Shamim Saleha 1, Muhammad Ajmal 2, Muhammad Jamil 1, Muhammad Nasir 2 and Abdul Hameed 2* 1Department of Biotechnology and Genetic Engineering, Kohat University of Science and Technology, Kohat 26000, Khyber Paktoonkhwa, Pakistan. 2Institute of Biomedical and Genetic Engineering, G.P.O. box 2891, 24-Mauve Area, G-9/1, Islamabad, Pakistan. Accepted 29 April, 2011 Primary microcephaly (MCPH) is an autosomal-recessive congenital disorder characterized by smaller- than-normal brain size and mental retardation. MCPH is genetically heterogeneous with six known loci: MCPH1 to MCPH7. The abnormal spindle-like, microcephaly associated (ASPM) gene at MCPH5 locus, which accounts for 37 to 54% of MCPH, appears to be the most common cause of microcephaly. More than 50% of the MCPH families genetically analyzed in Pakistan were mapped to MCPH5 locus including both families in this study. On mutation screening of ASPM gene by PCR amplification and direct DNA sequencing, a common c.3978G>A transition was identified in exon 17 of ASPM gene to be responsible for diseased phenotype in both families. This change results to the substitution of an amino acid residue at position 1326 from tryptophan to a stop codon (p.Trp1326Stop). The same mutation was also identified in several other families of Pakistani origin.
    [Show full text]
  • Molecular Genetics of Microcephaly Primary Hereditary: an Overview
    brain sciences Review Molecular Genetics of Microcephaly Primary Hereditary: An Overview Nikistratos Siskos † , Electra Stylianopoulou †, Georgios Skavdis and Maria E. Grigoriou * Department of Molecular Biology & Genetics, Democritus University of Thrace, 68100 Alexandroupolis, Greece; [email protected] (N.S.); [email protected] (E.S.); [email protected] (G.S.) * Correspondence: [email protected] † Equal contribution. Abstract: MicroCephaly Primary Hereditary (MCPH) is a rare congenital neurodevelopmental disorder characterized by a significant reduction of the occipitofrontal head circumference and mild to moderate mental disability. Patients have small brains, though with overall normal architecture; therefore, studying MCPH can reveal not only the pathological mechanisms leading to this condition, but also the mechanisms operating during normal development. MCPH is genetically heterogeneous, with 27 genes listed so far in the Online Mendelian Inheritance in Man (OMIM) database. In this review, we discuss the role of MCPH proteins and delineate the molecular mechanisms and common pathways in which they participate. Keywords: microcephaly; MCPH; MCPH1–MCPH27; molecular genetics; cell cycle 1. Introduction Citation: Siskos, N.; Stylianopoulou, Microcephaly, from the Greek word µικρoκεϕαλi´α (mikrokephalia), meaning small E.; Skavdis, G.; Grigoriou, M.E. head, is a term used to describe a cranium with reduction of the occipitofrontal head circum- Molecular Genetics of Microcephaly ference equal, or more that teo standard deviations
    [Show full text]
  • Review Article Molecular and Cellular Basis of Autosomal Recessive Primary Microcephaly
    Hindawi Publishing Corporation BioMed Research International Volume 2014, Article ID 547986, 13 pages http://dx.doi.org/10.1155/2014/547986 Review Article Molecular and Cellular Basis of Autosomal Recessive Primary Microcephaly Marine Barbelanne1,2 and William Y. Tsang1,2,3 1 Institut de Recherches Cliniques de Montreal,´ 110 avenue des Pins Ouest, Montreal,QC,CanadaH2W1R7´ 2 FacultedeM´ edecine,´ UniversitedeMontr´ eal,´ Montreal,QC,CanadaH3C3J7´ 3 Division of Experimental Medicine, McGill University, Montreal,´ QC, Canada H3A 1A3 Correspondence should be addressed to William Y. Tsang; [email protected] Received 16 July 2014; Revised 18 September 2014; Accepted 18 September 2014; Published 8 December 2014 Academic Editor: Saulius Butenas Copyright © 2014 M. Barbelanne and W. Y. Tsang. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Autosomal recessive primary microcephaly (MCPH) is a rare hereditary neurodevelopmental disorder characterized by a marked reduction in brain size and intellectual disability. MCPH is genetically heterogeneous and can exhibit additional clinical features that overlap with related disorders including Seckel syndrome, Meier-Gorlin syndrome, and microcephalic osteodysplastic dwarfism. In this review, we discuss the key proteins mutated in MCPH. To date, MCPH-causing mutations have been identified in twelve different genes, many of which encode proteins that are involved in cell cycle regulation or are present at the centrosome, an organelle crucial for mitotic spindle assembly and cell division. We highlight recent findings on MCPH proteins with regard to their role in cell cycle progression, centrosome function, and early brain development.
    [Show full text]
  • New Experimental Evidence and Its Consequences for Linguistics
    Genetic influences on tone? New experimental evidence and its consequences for linguistics. Dan Dediu1* and D. Robert Ladd2 1 Laboratoire Dynamique Du Langage UMR 5596, Université Lumière Lyon 2, Lyon, France 2 Linguistics and English Language, The University of Edinburgh, Edinburgh, UK * Corresponding author: [email protected] Abstract: In 2007, we used a cross-linguistic statistical analysis to show that there seems to be a negative correlation between the population frequency of the “derived” alleles of two genes involved in brain growth and development, ASPM and Microcephalin (or MCHP1), and the use of tone in the language(s) spoken by the population. Despite our best attempts at disentangling the confounding effects of contact and genealogical inheritance, and the fact that these correlations stood out among millions of similar correlations between multiple genetic markers and linguistic features, this was, at best, a statistical association and, at worst, a false positive. However, new experimental evidence has recently been published independently of us, showing that the negative correlation between the “derived” allele of ASPM and tone perception and/or processing is present at the level of inter-individual differences among more than 400 native speakers of Cantonese, providing strong support for our initial findings (on the other hand, there is no signal for MCPH1). Here we contextualize and summarize these experimental findings, we address some remaining puzzles (including MCHP1 and the absence of tone in Australia), and we discuss the implications of these results for the language sciences. Genes & tone: a comment on new experimental evidence and its consequences Introduction: genetic influences on language and speech At the most general level, it is beyond debate that there is something about the human genome that makes language possible.
    [Show full text]
  • Print ACNR MA05
    Review Article The Genetics of Primary Microcephaly Clinical definition MCPH5 Autosomal recessive primary microcephaly (MCPH) is the MCPH5 mutation is the most common cause (~50% of term used to describe a genetically determined form of cases) of the MCPH phenotype.5 It is a large gene and microcephaly previously referred to as microcephaly vera or encodes the human orthologue of the Drosophila gene abnor- true microcephaly.1,2 It is clinically diagnosed using the follow- mal spindle (asp), called “abnormal spindle mutated in ing guidelines; microcephaly” (ASPM). The reported mutations are spread 1. Microcephaly (> -3SD) is present at birth. throughout the ASPM gene and result in truncated ASPM 2. Degree of microcephaly does not progress throughout protein products ranging in size from 116 – 3357aas.1,6 lifetime. ASPM is predicted to contain an N-terminal microtubule Gemma Thornton 3. Mild to severe mental retardation without other neuro- binding domain, two calponin homology domains (com- logical findings (fits are rare). mon to actin binding proteins), 81 isoleucine-glutamine 4. Height/weight/appearance are all normal (except with (IQ) repeat motifs (predicted to change conformation when mutation in MCPH1, where some reduction in height bound to calmodulin), and a C-terminal region of unknown may be observed). function.4 MCPH affects neurogenesis in utero. The brains of affected Structural projections and comparison with myosin sug- individuals are characterised by a significant reduction in the gest that when ASPM is present at the centrosome, it assumes size of the cerebral cortex (presumably the cause of the a semi-rigid-rod-conformation, with microtubules bound observed mental retardation).
    [Show full text]
  • Expression of DNA Damage Response Proteins and Associations with Clinicopathologic Characteristics in Chinese Familial Breast Cancer Patients with BRCA1/2 Mutations
    Journal of J Breast Cancer 2018 September; 21(3): 297-305 https://doi.org/10.4048/jbc.2018.21.e38 Breast Cancer ORIGINAL ARTICLE Expression of DNA Damage Response Proteins and Associations with Clinicopathologic Characteristics in Chinese Familial Breast Cancer Patients with BRCA1/2 Mutations Xinyi Zhu*, Tian Tian1,*, Miao Ruan1, Jia Rao1, Wentao Yang1, Xu Cai1, Menghong Sun2, Guangqi Qin2, Zhonghua Zhao3, Jiong Wu, Zhimin Shao, Ruohong Shui1, Zhen Hu Departments of Breast Surgery, 1Pathology, and 2Tissue Bank, Fudan University Shanghai Cancer Center, Shanghai; 3Department of Pathology, Shanghai Medical College, Fudan University, Shanghai, China Purpose: The characteristic expression of DNA damage re- mal growth factor receptor 2 negative, low Ki-67, and positive sponse proteins in familial breast cancers with BRCA1, BRCA2, CK5/6. BRCA1 mutated tumors had lower CHEK2 and higher or non-BRCA1/2 mutations has not been analyzed in Chinese cytoplasmic BRIT1 expression than BRCA2 and non-BRCA1/2 patients. Our study aimed to assess the differential expression of mutation tumors. BRCA2-associated tumors showed higher microcephalin 1 (BRIT1), ATM serine/threonine kinase (ATM), CHEK2 and cytoplasmic RAD51 expression than those in other checkpoint kinase 2 (CHEK2), BRCA1, RAD51 recombinase groups. Nuclear PARP-1 expression in BRCA1/2-associated tu- (RAD51), and poly (ADP-ribose) polymerase 1 (PARP-1) and es- mors was significantly higher than in non-BRCA1/2 mutation tu- tablish the profile of Chinese familial breast cancers with different mors. Moreover, we found quite a few of negative PARP-1 ex- mutation status. Methods: We constructed five tissue microar- pression cases in BRCA1/2 mutated groups.
    [Show full text]
  • Novel SASS6 Compound Heterozygous Mutations in A
    Clinica Chimica Acta 491 (2019) 15–18 Contents lists available at ScienceDirect Clinica Chimica Acta journal homepage: www.elsevier.com/locate/cca Case report Novel SASS6 compound heterozygous mutations in a Chinese family with primary autosomal recessive microcephaly T ⁎ ⁎ Yanghui Zhanga,b,1, Haoxian Lia,b,1, Jialun Panga,b, Ying Penga,b, Li Shua,b, , Hua Wanga,b, a Hunan Provincial Maternal and Child Health Care Hospital, NO.53 Xiangchun Road, Changsha, Hunan 410008, China b NHC Key Laboratory of Birth Defects Research, Prevention and Treatment (Hunan Provincial Maternal and Child Health Care Hospital), NO.53 Xiangchun Road, Changsha, Hunan 410008, China ARTICLE INFO ABSTRACT Keywords: Primary autosomal recessive microcephaly (MCPH) is a rare hereditary disease characterized by congenitally Primary autosomal recessive microcephaly small with brain circumference of the head below 3 standard deviations (SD). By far, 18 MCPH genes have been SASS6 reported to be associated with the disease. SASS6 gene functioned in assembly of centrioles that the majority of Splice site mutation MCPH genes present at the centrosome. There was only research reporting a homozygous missense mutation in Fetus SASS6 gene detected in a consanguineous Pakistani family. By conducting Whole-exome sequencing (WES) and Sanger sequencing on the family trio, we identified two novel splice site mutations c.127-13A > G and c.1867+2T > A in compound heterozygous hereditary form in the SASS6 gene. The two mutations were con- firmed to alter mRNA splicing by RT-PCR assay. Our finding supported the role of SASS6 in the pathogenesis of microcephaly, expanding mutation spectrums and contributing to understanding of molecular mechanisms of MCPH.
    [Show full text]
  • Autosomal Recessive Primary Microcephaly (MCPH): an Update
    Review Article 135 Autosomal Recessive Primary Microcephaly (MCPH): An Update Sami Zaqout1,2,3,4 Deborah Morris-Rosendahl5,6 Angela M. Kaindl1,2,3,4 1 Institute of Cell Biology and Neurobiology, Charité – Address for correspondence Angela M. Kaindl, MD, PhD, Institute for Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany Cell Biology and Neurobiology, Charité - Universitätsmedizin Berlin, 2 Center for Chronically Sick Children (Sozialpädiatrisches Zentrum), Campus Mitte, Charitéplatz 1, 10117 Berlin, Germany Charité – Universitätsmedizin Berlin, Berlin, Germany (e-mail: [email protected]). 3 Berlin Institute of Health, Berlin, Germany 4 Department of Pediatric Neurology, Charité – Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany 5 Clinical Genetics and Genomics, Royal Brompton & Harefield NHS Foundation Trust, London, United Kingdom 6 National Heart and Lung Institute, Imperial College London, London, United Kingdom Neuropediatrics 2017;48:135–142. Abstract Autosomal recessive primary microcephaly (MCPH; MicroCephaly Primary Hereditary) is Keywords a genetically heterogeneous neurodevelopmental disorder characterized by a signi- ► MCPH ficantly reduced head circumference present already at birth and intellectual disability. ► microcephaly Inconsistent features include hyperactivity, an expressive speech disorder, and epilepsy. ► intellectual disability Here, we provide a brief overview on this rare disorder pertinent for clinicians. Introduction Phenotype Features Microcephaly is the clinical sign of small cranium with a Individuals with MCPH display nonprogressive microcephaly significant reduction of the occipitofrontal head circumfer- at birth that can already be diagnosed in utero by the 24th ence (OFC) of more than two (microcephaly) or three (severe week of gestation using ultrasound or magnetic resonance microcephaly) standard deviations (SDs) below the mean for imaging (MRI).7 MCPH has been reported in more than 300 age, sex, and ethnicity.
    [Show full text]